zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2023 / Fespixon cream has been approved to be reimbursed by the National Health Insurance

Fespixon cream has been approved to be reimbursed by the National Health Insurance

2023-07-14

Published Date:2023-07-14

Original Link:https://www.onenessbio.com/en/news_detail234_2.htm

No 2 Date of announcement 2023/07/14 Time of announcement 20:18:26
Subject Fespixon cream has been approved to be reimbursed by the National Health Insurance
To which item it meets paragraph 53 Date of events 2023/07/14
Statement
  1. Date of occurrence of the event:2023/07/14
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:Oneness was notified that Fespixon cream has been included in the NHI reimbursement. The reimbursement price will be NT$9,800 per tube and become effective as of 2023/08/01.
  6. Countermeasures:NA
  7. Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):NA